The US Food and Drug Administration on Saturday granted expanded emergency use authorisation for Novavax's COVID-19 vaccine Adjuvanted for adolescents aged between 12 and 17 years
Posted from: 0001-01-01 00:00:00Z2022-08-21 00:12:14Z[]this blog via Microsoft Power Automate.
